stockrowGuardant Health, Inc. (GH) vs Medpace Holdings, Inc. (MEDP)
- Guardant Health, Inc. GH 150.48 −1.92%
- Medpace Holdings, Inc. MEDP 652.02 +2.68%
Guardant Health, Inc. and Medpace Holdings, Inc. are both Diagnostics & Research companies. Guardant Health, Inc. is the larger, with a market value of $20.6B against $17.8B — 1.2× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Medpace Holdings, Inc. trades at 34.6×. Guardant Health, Inc. grew revenue faster over the last twelve months: 41.7% against 20.4%. Medpace Holdings, Inc. has the higher net margin (18.2% vs −37.9%) and the higher return on invested capital (0.00% vs −25.7%). Across the 18 metrics below, Medpace Holdings, Inc. leads on 13 and Guardant Health, Inc. on 5.
Valuation
Profitability
| Metric | GH | MEDP | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.19% | 72.24% | 48.32% |
| Operating margin | (39.41%) | 21.39% | (5.68%) |
| Net margin | (37.93%) | 18.24% | (4.10%) |
| Free cash flow margin | (18.15%) | 23.52% | 0.00% |
| Return on equity | 153.90% | 117.88% | 0.00% |
| Return on assets | (30.68%) | 25.54% | (6.05%) |
| Return on invested capital | (25.68%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack